Browsing: Food and Drug Administration

The agency states that the changes are based on a review of more recent clinical evidence.

FDA Commissioner Marty Makary says he believes “everything should be over the counter” unless a drug is unsafe, addictive or requires monitoring

In a historic first for the agency, FDA Commissioner Martin A. Makary, M.D., M.P.H. announced an aggressive timeline to scale use of artificial intelligence